Suraksha Diagnostic Limited (NSE:SURAKSHA)
India · Delayed Price · Currency is INR 321.70
-10.30 (-3.10%)
Oct 7, 2026, 3:29 PM IST
Suraksha Diagnostic Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 16,754 | 11,872 | 13,499 | - | - | - | |
Market Cap Growth | 7.52% | -12.06% | - | - | - | - |
Enterprise Value | 17,781 | 12,603 | 13,781 | - | - | - |
Last Close Price | 321.70 | 227.60 | 258.80 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 46.77 | 36.88 | 42.42 | - | - | - |
Forward PE | 41.78 | 30.70 | 35.88 | - | - | - |
PS Ratio | 5.15 | 3.83 | 5.36 | - | - | - |
PB Ratio | 6.88 | 4.88 | 6.42 | - | - | - |
P/TBV Ratio | 7.04 | 4.99 | 6.45 | - | - | - |
P/FCF Ratio | 115.67 | 81.96 | 63.27 | - | - | - |
P/OCF Ratio | 20.47 | 14.51 | 21.31 | - | - | - |
PEG Ratio | - | 1.12 | 1.24 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 5.46 | 4.06 | 5.47 | - | - | - |
EV/EBITDA Ratio | 16.57 | 16.37 | 21.29 | - | - | - |
EV/EBIT Ratio | 29.56 | 23.24 | 29.83 | - | - | - |
EV/FCF Ratio | 122.76 | 87.01 | 64.59 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.54 | 0.54 | 0.42 | 0.51 | 0.62 | 0.68 |
Debt / EBITDA Ratio | 1.21 | 1.37 | 1.10 | 1.26 | 2.11 | 1.57 |
Debt / FCF Ratio | - | 9.00 | 4.17 | 6.03 | 3.13 | 2.59 |
Net Debt / Equity Ratio | 0.43 | 0.45 | 0.34 | 0.20 | 0.27 | 0.38 |
Net Debt / EBITDA Ratio | 0.97 | 1.41 | 1.10 | 0.64 | 1.40 | 1.09 |
Net Debt / FCF Ratio | - | 7.50 | 3.32 | 2.36 | 1.35 | 1.42 |
Asset Turnover | - | 0.79 | 0.80 | 0.75 | 0.68 | 1.00 |
Inventory Turnover | - | 5.64 | 5.12 | 5.51 | 5.99 | 13.14 |
Quick Ratio | - | 0.75 | 0.78 | 1.62 | 1.56 | 1.35 |
Current Ratio | - | 1.05 | 1.10 | 1.84 | 1.78 | 1.64 |
Return on Equity (ROE) | - | 13.84% | 15.91% | 13.82% | 4.03% | 15.31% |
Return on Assets (ROA) | - | 8.67% | 9.11% | 8.52% | 3.29% | 9.98% |
Return on Invested Capital (ROIC) | 12.40% | 12.07% | 13.95% | 14.14% | 6.64% | 16.03% |
Return on Capital Employed (ROCE) | - | 14.00% | 15.90% | 15.20% | 6.00% | 15.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.14% | 2.71% | 2.36% | - | - | - |
FCF Yield | 0.86% | 1.22% | 1.58% | - | - | - |
Dividend Yield | 0.16% | 0.22% | - | - | - | - |
Buyback Yield / Dilution | -0.44% | - | 2.29% | - | - | 0.02% |
Total Shareholder Return | -0.28% | 0.22% | 2.29% | - | - | 0.02% |